Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.
Dai ChiharaNathan H FowlerYasuhiro OkiMichelle A FanaleLuis E FayadJason R WestinFredrick B HagemeisterPublished in: British journal of haematology (2016)